| Financial Year |
March 31 2023 |
| Monetary Funds |
6,317,086,919.51 |
| Held-for-trading Financial Assets |
1,551,478,962.54 |
| Notes Receivable |
33,045,760.03 |
| Accounts Receivable |
3,816,454,369.03 |
| Advances to Suppliers |
2,372,264,127.99 |
| Other Receivables |
381,977,499.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,817,874,878.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,180,299.73 |
| Other Current Assets |
175,877,818.82 |
| Total Current Assets |
16,467,240,634.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
91,052.94 |
| Long-term Equity Investment |
653,577,791.87 |
| Investment Properties |
207,747,207.94 |
| Fixed Assetes |
1,395,858,983.40 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,582,867,007.39 |
| R&D expenses |
281,961,214.54 |
| Goodwill |
803,944,418.76 |
| Long-Term Deferred and Prepaid Expenses |
59,590,466.25 |
| Deferred Income Tax Assets |
266,842,036.86 |
| Other Non-Current Assets |
366,551,831.94 |
| Sub-Total of Non-Current Assets |
7,448,376,974.77 |
| Total Assets |
23,915,617,609.76 |
| Short-Term Loans |
310,081,992.75 |
| Trading Financial liabilities |
-- |
| Notes Payable |
670,316,765.44 |
| Accounts Payable |
2,086,732,569.55 |
| Accounts Received In Advance |
5,930,774.61 |
| Employee Compensation Payable |
125,668,654.41 |
| Taxes Payable |
250,847,238.11 |
| Interest Payable |
-- |
| Dividend Payable |
50,972,057.41 |
| Other payables |
413,560,292.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
71,977,456.65 |
| Other Current Liabilities |
64,463,411.52 |
| Sub-Total of Current Liabilities |
5,562,424,250.43 |
| Long-term Loans |
43,645,466.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
19,764,419.91 |
| Deferred Income Tax Liabilities |
59,999,096.09 |
| Other Non-Current Liabilities |
2,044,991.66 |
| Sub-Total of Non-Current Liabilities |
288,739,499.13 |
| Total Liabilities |
5,851,163,749.56 |
| Paid-In Capital(Or Share Stock) |
1,852,884,638.00 |
| Capital Surplus |
813,500,412.93 |
| Surplus Reserve |
974,704,528.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
10,582,334,416.81 |
| Minority Stockholder's Interest |
3,674,898,771.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,389,555,088.28 |
| Owner's Equity（Stockholder's Equity） |
18,064,453,860.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,915,617,609.76 |
